Certara, Inc. — Investor Relations & Filings
Certara, Inc. is a company that accelerates drug discovery and development through the use of proprietary biosimulation software, technology, and expert services. It provides an end-to-end platform that supports clients across the entire drug development lifecycle, from discovery and preclinical research to clinical trials, regulatory submissions, and market access. The company's solutions leverage predictive simulation, data-driven modeling, and advanced analytics to help pharmaceutical and biotechnology organizations optimize trial design, justify dosing decisions, and navigate regulatory requirements. Key software products include Simcyp, Phoenix, and Pinnacle 21. Certara's offerings are designed to de-risk development, enhance efficiency, and increase the likelihood of bringing new medicines to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Certara, Inc. (0001827090) (Filer) | 2026-05-11 | English | |
| 8-K - Certara, Inc. (0001827090) (Filer) | 2026-05-11 | English | |
| 8-K - Certara, Inc. (0001827090) (Filer) | 2026-04-22 | English | |
| ARS - Certara, Inc. (0001827090) (Filer) | 2026-04-03 | English | |
| DEF 14A - Certara, Inc. (0001827090) (Filer) | 2026-04-03 | English | |
| 4 - CERTARA, INC. (0001827090) (Filer) | 2026-03-02 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 44937560 | 10-Q - Certara, Inc. (0001827090) (Filer) | 2026-05-11 | English | ||
| 44936931 | 8-K - Certara, Inc. (0001827090) (Filer) | 2026-05-11 | English | ||
| 35223149 | 8-K - Certara, Inc. (0001827090) (Filer) | 2026-04-22 | English | ||
| 33256151 | ARS - Certara, Inc. (0001827090) (Filer) | 2026-04-03 | English | ||
| 33255090 | DEF 14A - Certara, Inc. (0001827090) (Filer) | 2026-04-03 | English | ||
| 32899219 | 4 - CERTARA, INC. (0001827090) (Filer) | 2026-03-02 | English | ||
| 32899221 | 10-K - CERTARA, INC. (0001827090) (Filer) | 2026-02-26 | English | ||
| 32899220 | 8-K - CERTARA, INC. (0001827090) (Filer) | 2026-02-26 | English | ||
| 13319431 | Director's Dealing 2026 | 2026-01-12 | English | ||
|
2025
6 filings
| |||||
| 13319432 | FORM 8-K | 2025-12-11 | English | ||
| 13319433 | Major Shareholding Notification 2025 | 2025-11-25 | English | ||
| 13319434 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13319435 | Director's Dealing 2025 | 2025-11-12 | English | ||
| 13319436 | 10-Q | 2025-11-06 | English | ||
| 13319437 | 8-K | 2025-11-06 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
QUIA PHARMA AB
Develops medicines using a proprietary drug delivery platfo…
|
QUIA | SE | Professional, scientific and te… |
|
Qurient Co., Ltd.
Clinical-stage biopharma developing drugs for oncology, cGv…
|
115180 | KR | Professional, scientific and te… |
|
RACURA ONCOLOGY LTD
Clinical-stage developer of precision oncology therapeutics…
|
RAC | AU | Professional, scientific and te… |
|
RADIOPHARM THERANOSTICS LIMITED
Clinical-stage company developing radiopharmaceutical produ…
|
RAD | AU | Professional, scientific and te… |
|
Radiopharm Theranostics Ltd
Clinical-stage company developing radiopharmaceuticals for …
|
RADX | US | Professional, scientific and te… |
|
Rafael Holdings, Inc.
Invests in and develops therapies for cancer and rare genet…
|
RFL | US | Professional, scientific and te… |
|
Rain Enhancement Technologies Holdco, Inc.
Develops ionization-based weather modification technology f…
|
RAIN | US | Professional, scientific and te… |
|
Rakovina Therapeutics Inc.
Biopharma developing targeted cancer treatments using AI to…
|
RKV | CA | Professional, scientific and te… |
|
Rallybio Corp
A clinical-stage biotech company developing therapies for s…
|
RLYB | US | Professional, scientific and te… |
|
RaQualia Pharma Inc.
Develops and out-licenses innovative small molecule drug co…
|
4579 | JP | Professional, scientific and te… |
Certara, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31699/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31699 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31699 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31699 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31699}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Certara, Inc. (id: 31699)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.